The National Comprehensive Cancer Network has published updates to its clinical practice guidelines for follicular lymphoma and diffuse large B-cell lymphoma. READ MORE
Rates of survival have increased in patients with stage III to IV Hodgkin lymphoma over 3 decades as a result of improvements in the United States health care system.
Study: TKI Discontinuation Should Be Considered in Patients With CML Achieving Deep Molecular Response
Stopping tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia who have achieved deep molecular response could help reduce health expenditure.
Referral of newly diagnosed adolescent patients with acute lymphoblastic leukemia to pediatric and National Cancer Institute-designated centers should be strongly recommended.
Survival outcomes may be worse for patients with ALL living in intermediate and high socioeconomically deprived areas as well as for those treated in hospitals with lower volumes of patients.
Research in Review
Nurse navigation focused on the patient and family across the care continuum can effectively guide patients with blood cancer to better care and quality of life.
The National Comprehensive Cancer Network has published updates to its clinical practice guidelines for follicular lymphoma and diffuse large B-cell lymphoma.
Catch up on some of the most recent and practice-changing guideline updates in blood malignancies regarding treatment approaches and prognostic indicators.
The National Comprehensive Cancer Network has issued updates to the primary and second-line therapy options for the treatment of Hodgkin lymphoma.
International Workshop on CLL Revises Consensus Guideline Criteria for Prognostic Indicators, Response Assessments
Major advances in the biology and treatment of patients with CLL have prompted the International Workshop on CLL to evaluate and revise the criteria for their consensus guideline in this disease setting.